ReviewTherapeutic advances in medical oncology2020

Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitors.

Pascal Hammel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.